|By PR Newswire||
|April 23, 2014 11:00 AM EDT||
MOUNTAIN VIEW, Calif., April 23, 2014 /PRNewswire/ -- "Preventing Drug-Related Patient Injury and Death with Advanced, Cost-Effective Technology" is the topic Alan Jacobs, M.D., Ph.D., CEO and founder of PerceptiMed, will address at the Bio2Device lecture. The lecture will take place May 6th at the Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA at 8:30 a.m.
Each year more than 800,000 preventable drug-related injuries occur in long-term care facilities in the U.S. Additionally, national studies of retail pharmacy prescription-dispensing accuracy document an average error rate of 1.7%, or more than 68 million errors overall, with 4.4 million of them having the potential to cause serious harm.
Innovative, cost-effective systems for medication dispensing and administration in long-term care facilities and pharmacies are urgently needed to prevent these serious errors.
Dr. Jacobs is the co-inventor of the VeriFill IdentRx™ medication verification system, which removes the margin for human error in oral medication dispensing and administration. He will discuss how new technologies such as this will help eliminate the factor of human error in prescription pill dispensing.
Dr. Alan Jacobs has extensive experience leading international teams in the research and development of therapeutics and medical devices. He received a B.S.E.E. from Cornell University and a M.S.E.E from Stanford University. He also holds a Medical Doctorate from the School of Medicine at University of Pennsylvania and a Ph.D. from the David Mahoney Institute of Neuroscience, University of Pennsylvania, where he was a Fellow in the Medical Scientist Training Program of the National Institute of General Medical Sciences. Dr. Jacobs completed an internship in General Surgery and was a resident in neurological surgery at the University of California, San Francisco Medical Center.
PerceptiMed's products make the dispensing and administration of prescription drugs safer, reducing injuries and death. Its groundbreaking VeriFill™ technology removes the margin of human error and sets the industry standard for medication verification. www.perceptimed.com
About Bio2Device Group (B2DG)
B2DG is a premier organization dedicated to all professionals in the Life Sciences industry within the San Francisco Bay Area. Membership is free and open to anyone in the pharmaceutical, biotechnology, medical device, diagnostics, healthcare, life sciences tools and laboratory service industries. Its events provide the latest industry information through weekly educational programs and face-to-face interactive opportunities to build and maintain a career network. www.bio2devicegroup.org
SOURCE PerceptiMed, Inc.
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
Jul. 25, 2016 12:45 AM EDT Reads: 2,142
Basho Technologies has announced the latest release of Basho Riak TS, version 1.3. Riak TS is an enterprise-grade NoSQL database optimized for Internet of Things (IoT). The open source version enables developers to download the software for free and use it in production as well as make contributions to the code and develop applications around Riak TS. Enhancements to Riak TS make it quick, easy and cost-effective to spin up an instance to test new ideas and build IoT applications. In addition to...
Jul. 25, 2016 12:30 AM EDT Reads: 1,861
Jul. 25, 2016 12:15 AM EDT Reads: 1,399
Jul. 25, 2016 12:15 AM EDT Reads: 2,474
Jul. 24, 2016 11:30 PM EDT Reads: 1,253
Jul. 24, 2016 11:15 PM EDT Reads: 933
Jul. 24, 2016 11:00 PM EDT Reads: 1,616
Jul. 24, 2016 11:00 PM EDT Reads: 1,615
Jul. 24, 2016 11:00 PM EDT Reads: 1,479
Jul. 24, 2016 11:00 PM EDT Reads: 1,255
Jul. 24, 2016 10:45 PM EDT Reads: 1,970
Jul. 24, 2016 10:00 PM EDT Reads: 1,950
Jul. 24, 2016 09:45 PM EDT Reads: 1,625
Jul. 24, 2016 09:45 PM EDT Reads: 2,117
Jul. 24, 2016 09:45 PM EDT Reads: 1,903